Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer – possible implications for immunotherapy ; volume:130 ; number:1 ; day:1 ; month:12 ; year:2023 ; pages:143-150 ; date:1.2024
British journal of cancer ; 130, Heft 1 (1.12.2023), 143-150, 1.2024
- Creator
-
Edin, Sofia
Gylling, Björn
Li, Xingru
Stenberg, Åsa
Löfgren-Burström, Anna
Zingmark, Carl
Guelpen, Bethany van
Ljuslinder, Ingrid
Ling, Agnes
Palmqvist, Richard
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-023-02483-9
- URN
-
urn:nbn:de:101:1-2024032510123598260979
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Edin, Sofia
- Gylling, Björn
- Li, Xingru
- Stenberg, Åsa
- Löfgren-Burström, Anna
- Zingmark, Carl
- Guelpen, Bethany van
- Ljuslinder, Ingrid
- Ling, Agnes
- Palmqvist, Richard
- SpringerLink (Online service)
Other Objects (12)
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
KRAS and BRAF mutational status in colon cancer from Albanian patients
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Bestimmung von KRAS und BRAF bei Patienten mit metastasiertem kolorektalem Karzinom : eine retrospektive Analyse
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
KRAS and BRAF mutational status in colon cancer from Albanian patients
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Bestimmung von KRAS und BRAF bei Patienten mit metastasiertem kolorektalem Karzinom : eine retrospektive Analyse
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions
Prävalenz und Heterogenität von KRAS-, BRAF- und PIK3CA-Mutationen in Magenkarzinomen und ihren Metastasen
KRAS- und BRAF-Mutationen im lokal fortgeschrittenen Rektumkarzinom
Vergleich des KRAS/BRAF-Mutationsstatus zwischen Primärtumoren und Metastasen kolorektaler Karzinome
KRAS and BRAF mutational status in colon cancer from Albanian patients
Ciliated muconodular papillary tumors of the lung with KRAS/BRAF/AKT1 mutation
Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
Targeting neoepitopes derived from KRAS mutations for cancer-specific immunotherapy
Bestimmung von KRAS und BRAF bei Patienten mit metastasiertem kolorektalem Karzinom : eine retrospektive Analyse
Pyrosequencing data analysis software: a useful tool for EGFR, KRAS, and BRAF mutation analysis
Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions